Sign in

CIK 0001649094

  • Large accelerated filer

Vaxcyte, Inc.

Sign in to watch
Ticker
PCVX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464233385
Phone
+1 650-837-0111
Business address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
Former names
SutroVax, Inc.
  1. 4 Grant or award Director acquired 2,500 shares (grant or award)
  2. 4 Grant or award Director acquired 2,500 shares (grant or award)
  3. 4 Grant or award Director acquired 2,500 shares (grant or award)
  4. 4 Grant or award Director acquired 2,500 shares (grant or award)
  5. 4 Grant or award Director acquired 2,500 shares (grant or award)
  6. 4 Grant or award Director acquired 2,500 shares (grant or award)
  7. 4 Grant or award Director acquired 2,500 shares (grant or award)
  8. 4 Shares withheld for taxes SVP, Gen Counsel & Corp Sec gave up 645 shares (to pay taxes)
  9. 4 Grant or award SVP, Finance acquired 7,250 shares (grant or award)
  10. 4 Grant or award SVP, Gen Counsel & Corp Sec acquired 13,750 shares (grant or award)
  11. 4 Shares withheld for taxes Chief Operating Officer gave up 1,189 shares (to pay taxes)
  12. 4 Shares withheld for taxes President and CFO gave up 1,727 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Executive Officer gave up 3,099 shares (to pay taxes)
  14. 4 Open-market sale Director sold 315 shares at an average $46.12 ($14,526)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 22 · 421 filings